Chondrocyte apoptosis pathway

The chondrocyte apoptosis pathway refers to the series of molecular mechanisms, both intrinsic (mitochondrial) and extrinsic (death receptor-mediated), that orchestrate programmed cell death in chondrocytes. Apoptosis of chondrocytes is a central feature in the pathogenesis of osteoarthritis and other degenerative joint diseases, leading to cartilage degradation due to the poor reparative ability of chondrocytes[3][4]. Key regulators of the pathway include the caspase family of proteases, death receptors (such as Fas/CD95, TNFR1, TRAIL receptors), and Bcl-2 family proteins. Multiple signaling routes—such as the activation of TNF receptors, mitochondria permeabilization, and downstream caspase activation—contribute to the loss of chondrocyte viability. Various drugs (caspase inhibitors, chondroprotective agents like glucosamine and hyaluronic acid) and even genetic molecules (microRNAs, lncRNAs, circRNAs) have been explored to modulate this pathway therapeutically, largely for osteoarthritis[2][3][4][5][6]. However, since the chondrocyte apoptosis pathway comprises several molecular actors and cannot be classified as a single "target" (e.g., receptor, enzyme), it is not considered a canonical therapeutic target but rather a cellular process that contains multiple potential molecular targets.

Other names

Apoptosis pathway in chondrocytesChondrocyte death pathwayChondrocyte cell death signaling

Inhibition of caspases (e.g., caspase-3, caspase-9), inhibition of pro-apoptotic signaling through TNF receptor superfamily (e.g., death receptors Fas, TNFR1, TRAIL receptors), Bcl-2 family protein modulation, mTOR signaling modulation[2][3][4][5][6]